top of page

Global Cancer Early Detection

Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer

The Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CPDPC) was formed to undertake a comprehensive clinical, epidemiological, and biological characterization of patients with Chronic Pancreatitis including those with Acute Recurrent Pancreatitis and ARP.



The overriding two objectives of this research program are to pursue clinical research on Chronic Pancreatitis (including those with Acute Recurrent pancreatitis, ARP), by identifying and characterizing a large cohort of pediatric and adult patients with CP and ARP to encourage translational research focusing upon elucidating the pathogenesis that will provide the basis for understanding the natural history and developing means of diagnosis, treatment and clinical management of Chronic Pancreatitis and its sequela: chronic pain, pancreatic insufficiency and on pancreatic cancer and pancreatogenic Diabetes Mellitus (T3cDM) and their pathogenic interrelationships, by identifying and following a cohort of newly diagnosed diabetic patients in the setting of CP

Latest Publications

Category 1 (vetted by one of the CPDPC Working Groups)

Eibl G, Cruz-Monserrate Z, Korc M, Petrov MS, Goodarzi MO, Fisher WE, Habtezion A, Lugea A, Pandol SJ, Hart PA, Andersen DK; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer. J Acad Nutr Diet. 2018 Apr;118(4):555-567. doi: 10.1016/j.jand.2017.07.005. Epub 2017 Sep 12. PubMed PMID: 28919082; PubMed Central PMCID: PMC5845842.

Analyzing Scans
bottom of page